Showing results (71-80 of 104) with videos related to
Sort By:
Pageof 11
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2007
A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancerMark Lodge, Madelon Pijls-Johannesma, Lisa Stirk, et al.The Cochrane Database of Systematic Reviews|July 9, 2010
Vaccines for preventing influenza in healthy adultsTom Jefferson, Carlo Di Pietrantonj, Alessandro Rivetti, et al.The Cochrane Database of Systematic Reviews|February 2, 2018
Vaccines for preventing influenza in the elderlyVittorio Demicheli, Tom Jefferson, Carlo Di Pietrantonj, et al.International Journal of Technology Assessment in Health Care|March 10, 2015
Collaborative models for the joint production of core health technology assessments: negative and positive aspects for the joint work of different European agenciesAlessandra Lo Scalzo, Nicola Vicari, Mirella Corio, et al.Vaccine|November 27, 2002
The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI)Jan Bonhoeffer, Katrin Kohl, Robert Chen, et al.The Cochrane Database of Systematic Reviews|February 19, 2010
Vaccines for preventing influenza in the elderlyTom Jefferson, Carlo Di Pietrantonj, Lubna A Al-Ansary, et al.Viruses|July 27, 2022
A Hierarchical Framework for Assessing Transmission Causality of Respiratory VirusesTom Jefferson, Carl J Heneghan, Elizabeth Spencer, et al.BMJ (Clinical Research Ed.)|February 9, 2017
Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agenciesAngela Spelsberg, Christof Prugger, Peter Doshi, et al.BMJ Open|December 8, 2017
Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval processCarl J Heneghan, Ben Goldacre, Igho Onakpoya, et al.Vaccine|September 2, 2022
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adultsJoseph Fraiman, Juan Erviti, Mark Jones, et al.Pageof 11